EUVIMEDEUVIMED entdecken
Kohortenstudie

A single-centered, retrospective cohort study of critically ill COVID-19 patients: Is the heart at risk?

Annie Loraine E. Khan, Glenn Rose B. Advincula, Francis Charles L. Fernandez, Simonette Kristine T. Sawit

ASEAN Heart Journal · 2020

DOI: 10.31762/ahj2027.0201 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift ASEAN Heart Journal, 2020. Verfasst von Annie Loraine E. Khan und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVEThe Philippines has the highest COVID-19 mortality rate by country (per million) in South East Asia.We aim to explore predictors of mortality among critically ill COVID-19 patients. METHODSThis single-centered, retrospective cohort study included consecutive patients with confirmed COVID-19 infection and acute respiratory distress syndrome requiring mechanical ventilation and intensive care unit (ICU) admission at The Medical City hospital from March 6 to March 31, 2020.Clinical data were obtained from medical records review and compared between survivors and non-survivors. RESULTSAmong 30 patients (mean age 65±3 years, interquartile range 32-86; 63% male), hypertension (67%), diabetes mellitus (45%), hyperlipidemia (40%) and smoking history (30%) were common.Those with echocardiogram showed no left ventricular dysfunction except 1 (preexisting heart failure), despite elevated troponin and NT-pro BNP.All had sepsis; 87% had septic shock.Twenty two (73%) died, 6 (20%) discharged improved, 1 (3%) transferred to another hospital (outcome unknown), and 1 (3%) still admitted.Mean duration from ICU admission to death was 13 days for non-survivors.Use of norepinephrine plus vasopressin and unfractionated heparin (UFH) for thromboprophylaxis were significantly higher among non-survivors versus survivors.There was a nonsignificant trend towards a higher mean troponin and NT-proBNP among non-survivors versus survivors. CONCLUSIONWe report that use of norepinephrine plus vasopressin and UFH for thromboprophylaxis were predictors of mortality among critically ill COVID-19 patients.Mean survival time of non-survivors is likely to be 13 days after ICU admission.

Zitieren

APA

Khan, A. L. E., Advincula, G. R. B., Fernandez, F. C. L., & Sawit, S. K. T. (2020). A single-centered, retrospective cohort study of critically ill COVID-19 patients: Is the heart at risk?. ASEAN Heart Journal. https://doi.org/10.31762/ahj2027.0201

Vancouver

Khan ALE, Advincula GRB, Fernandez FCL, Sawit SKT. A single-centered, retrospective cohort study of critically ill COVID-19 patients: Is the heart at risk?. ASEAN Heart Journal. 2020. doi:10.31762/ahj2027.0201

BibTeX
@article{Khan2020,
  author = {Khan, Annie Loraine E. and Advincula, Glenn Rose B. and Fernandez, Francis Charles L. and Sawit, Simonette Kristine T.},
  title = {A single-centered, retrospective cohort study of critically ill COVID-19 patients: Is the heart at risk?},
  journal = {ASEAN Heart Journal},
  year = {2020},
  doi = {10.31762/ahj2027.0201}
}
Kostenlos starten →